F-group (family)
2003.1.5.11 PARP_regulatory
Ligands and drugs
48
Member domains
33
with ligand contacts (≤ 4 Å)
68.8% of members
35
with DrugDomain annotations
72.9% of members
25
with a DrugBank compound
52.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2003.1.5.11 belongs to X-group 2003 Rossmann-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01752 | SAH | S-adenosyl-L-homocysteine | 19 |
| DB01960 | M7G | 7-methyl-7,8-dihydroguanosine-5'-diphosphate | 3 |
| DB01910 | SFG | Sinefungin | 2 |
| DB03358 | MGT | 7-Methyl-7,8-dihydroguanosine 5'-(tetrahydrogen triphosphate) | 2 |
| DB03493 | MG7 | 7-Methylguanosine | 2 |
| DB03685 | U5P | Uridine monophosphate | 2 |
| DB03958 | GTG | 7-methyl-guanosine-5'-triphosphate-5'-guanosine | 2 |
| DB00118 | SAM | Ademetionine | 1 |
| DB01978 | NDM | 7,9-Dimethylguanine | 1 |
| DB03164 | M1A | 6-amino-1-methyl-7H-purin-1-ium | 1 |
| DB04103 | 3MC | 3-Methylcytosine | 1 |
| DB04314 | 1MC | 1-Methylcytosine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SAH | S-ADENOSYL-L-HOMOCYSTEINE | 19 |
| M7G | 7N-METHYL-8-HYDROGUANOSINE-5'-DIPHOSPHATE | 3 |
| MG7 | 7-METHYLGUANOSINE | 2 |
| MGT | 7N-METHYL-8-HYDROGUANOSINE-5'-TRIPHOSPHATE | 2 |
| SFG | SINEFUNGIN | 2 |
| UEM | (2~{S})-2-azanyl-4-[[(2~{S},3~{S},4~{R},5~{R})-5-[4-azanyl-5-(2-naphthalen-1-ylethynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylsulfanyl]butanoic acid | 2 |
| UF9 | (2~{S})-2-azanyl-4-[[(2~{S},3~{S},4~{R},5~{R})-5-[4-azanyl-5-(2-phenylethynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylsulfanyl]butanoic acid | 2 |
| UG9 | (2~{S})-2-azanyl-4-[[(2~{S},3~{S},4~{R},5~{R})-5-(4-azanyl-5-iodanyl-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methylsulfanyl]butanoic acid | 2 |
| UGR | (2~{S})-2-azanyl-4-[[(2~{S},3~{S},4~{R},5~{R})-5-[4-azanyl-5-(2-quinolin-3-ylethynyl)pyrrolo[2,3-d]pyrimidin-7-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylsulfanyl]butanoic acid | 2 |
| UH2 | (2~{S})-2-azanyl-4-[[(2~{S},3~{S},4~{R},5~{R})-5-[4-azanyl-5-[2-(1~{H}-benzimidazol-2-yl)ethynyl]pyrrolo[2,3-d]pyrimidin-7-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methylsulfanyl]butanoic acid | 2 |
| 1MC | 1-METHYLCYTOSINE | 1 |
| 3MA | 6-AMINO-3-METHYLPURINE | 1 |
| 3MC | 3-METHYLCYTOSINE | 1 |
| GTG | 7-METHYL-GUANOSINE-5'-TRIPHOSPHATE-5'-GUANOSINE | 1 |
| M1A | 6-AMINO-1-METHYLPURINE | 1 |
| NDM | 7,9-DIMETHYLGUANINE | 1 |
| SAM | S-ADENOSYLMETHIONINE | 1 |